BiomX Inc. Gains 59.6%
BiomX Inc. (PHGE:NYSEMKT) soared at $0.6, a gain of 59.6%. On Wed, May 20, 2026, PHGE:NYSEMKT hit a New 2-Week Intraday High of $0.71. The stock appeared on our News Catalysts scanner on Sat, May 16, 2026 at 02:40 AM in the 'EARNINGS' category. From Wed, May 06, 2026, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Jan 29, 2026 at $8.5 with a volume of 1M+.
About BiomX Inc. (PHGE:NYSEMKT)
BiomX Inc is a clinical stage microbiome company based in Israel. The company is engaged on developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectalcancer, and primary sclerosing cholangitis.
Top 10 Gainers:
- HCW Biologics Inc. (HCWB:NASDAQ), 129.25%
- Silexion Therapeutics Corp (SLXN:NASDAQ), 96.95%
- GCL Global Holdings Ltd (GCL:NASDAQ), 72.46%
- BiomX Inc. (PHGE:NYSEMKT), 59.6%
- MetaVia Inc. (MTVA:NASDAQ), 53.72%
- Micware Co. Ltd. (MWC:NASDAQ), 51.48%
- TDH Holdings, Inc. (PETZ:NASDAQ), 41.98%
- MicroAlgo Inc. (MLGO:NASDAQ), 39.95%
- Immunovant, Inc. (IMVT:NASDAQ), 35.26%
- Rain Enhancement Technologies Holdco, Inc. (RAIN:NASDAQ), 34.67%